Table 5 Global Baseline and Thailand’s Progress Toward the Elimination of Hepatitis B and C by 2030
Target Area | Global Baseline 2015 | Thailand Estimates 2019 | WHO Target 2030 |
|---|---|---|---|
HBV birth dose | 38% | 99% | 90% |
HBV 3+ doses | 82% | 97% | 90% |
Blood safety | 89% | 100% | 100% |
Injection safety | 5% | 100% | 90% |
Syringes per PWID†| 20 | 24 | 300 |
HBV diagnosed | <  5% | 7% | 90% |
HBV treated | <  1% | 1% | 80% |
HCV diagnosed | <  5% | 36% | 90% |
HCV treated | < 1% | 11% | 80% |